Washington, DC Re: The Center, founded inis a national, non-partisan law organization that works to ensure fair access to Medicare and quality healthcare.
Healthcare players would welcome the clarity in a nebulous area of antitrust law, experts say, but it's not likely to change the FTC's enforcement approach. The commissioners are nearing a bipartisan agreement on principles for going after companies engaged in unfair competition, the Wall Street Journal reported this week citing unnamed sources.
A number of Republicans have argued that the lack of guidance leaves businesses vulnerable to enforcement actions for things they didn't know were illegal. Others, however, counter that it's best for the FTC to have flexible powers of enforcement to deal with new and changing business practices.
An FTC spokeswoman declined to comment on the matter Wednesday. The section of the law at issue is now used in situations that don't specifically violate antitrust laws but are nevertheless deemed out of bounds.
Feinstein said the law has most frequently been applied in situations involving invitations to collude, such as when one party proposes to a competitor that they both raise prices, but the competitor doesn't agree.
Because there's no agreement, there's no price-fixing violation. Robert Leibenluft, a former head of the healthcare division within the FTC's Bureau of Competition, said he suspects that whatever agreement is reached will be narrowly defined, especially if it's voted out unanimously.
That's partly because commissioners have long had trouble agreeing on principles surrounding unfair competition, even as they've faced pressure from Republicans to issue specific guidance.
InFTC leaders indicated they hoped to craft a policy statement, but that never happened. But the provision has been used only rarely in recent years and most of the cases were resolved with consent orders, leaving little case law as guidance.
Charles Johnson, a partner at Holland and Knight in Atlanta who focuses on public policy and complex business disputes, said an agreement could be a positive development for healthcare and other businesses.The Masimo Foundation for Ethics, Innovation, and Competition in Healthcare is committed to advancing positive change for the benefit of clinicians and patients everywhere..
We support programs, initiatives, and research designed to improve patient safety and outcomes, promote efficient and cost-effective healthcare delivery, and provide advanced healthcare to people worldwide who may not. Days before the midterms, 68% of voters say that health care is very or extremely important to how they plan to vote in this year’s elections, according to a new Cato Health Care.
Competition is supposed to be good for health care. Only with competition, it is said, will we get the highest quality health care at the lowest cost.
But is this true? Where’s the evidence? In the ’s capitated managed care was supposed to prove the benefits of competition.
Insurance. Jun 28, · BY MARTIN GAYNOR, FARZAD MOSTASHARI AND PAUL GINSBURG -- Political leaders need to act decisively to make health care markets work and provide relief for beleaguered American families.
Affiliation Process The Membership year brings the challenge of achieving a record 35th straight year of membership growth for HOSA.
The Problem. The U.S. health care system is inefficient, unreliable, and crushingly expensive. In other sectors, competition improves quality and efficiency, spurs innovation, and drives down costs.